ARCH Venture Fund VIII Overage, L.P.
CIK 1617237 · last filed 2023-09-20
ARCH Venture Fund VIII Overage, L.P. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for NMRA, was dated Sep 20, 2023. Across all open-market trades the lifetime net is +$335.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $7.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.80M
3
4
$335.43M
Holdings By Company
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-20 | NMRA | Mixed | +189,247,040 | $255.00M | EDGAR |
| 2022-09-15 | Codiak BioSciences, Inc. (CDAK) Delisted | Buy (P) | +35,000,000 | $52.50M | EDGAR |
| 2020-11-24 | QTRX | Other (J) | −5,779,599 | $0 | EDGAR |
| 2017-12-13 | QTRX | Mixed | +27,647,795 | $27.93M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.